Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
Sedlácek
P
P
Trka
J
J
Zuna
J
J
Hrusák
O
O
Honzátková-Krsková
L
L
Stary
J
J
D000818:Animals; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D050676:Core Binding Factor Alpha 2 Subunit; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology / Q000628:therapy; D018183:Transplantation Chimera; D014184:Transplantation, Homologous; D000097764:ETS Translocation Variant 6 Protein
D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein